HDM-1002
- Generic Name
- HDM-1002
A Relative Bioavailability and Food Effect Study of HDM1002 in Healthy Subjects
- First Posted Date
- 2024-09-23
- Last Posted Date
- 2024-09-23
- Target Recruit Count
- 33
- Registration Number
- NCT06608329
- Locations
- 🇨🇳
Hangzhou First People's Hospital, Hangzhou, Zhejiang, China
A Drug-Drug Interaction (DDI) Study of HDM1002 With Repaglinide, Atorvastatin, Digoxin and Rosuvastatin in Healthy Subjects
Phase 1
Not yet recruiting
- Conditions
- Healthy Adult SubjectOverweight Subject
- Interventions
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-09-19
- Target Recruit Count
- 30
- Registration Number
- NCT06601517
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, China
A Study To Characterize Mass Balance Of [14C] HDM1002 in Chinese Healthy Subjects
- First Posted Date
- 2024-08-28
- Last Posted Date
- 2024-08-28
- Target Recruit Count
- 10
- Registration Number
- NCT06576401
- Locations
- 🇨🇳
The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath